Challenger (ASX:CGF) said that TAL Dai-ichi Life Australia (TAL) has secured all necessary regulatory approvals, including from the Australian Prudential Regulation Authority, enabling TAL to complete its acquisition of an equity stake in the company, according to a Friday filing with the Australian bourse.
Upon completion, TAL will own a 19.9% equity stake in Challenger, the filing said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.